Flexion Therapeutics Inc

Flexion Therapeutics — Q1 2021 Earnings Presentation

5 slides from Flexion Therapeutics's earnings presentation, May 12, 2021

  1. Slide 1: Q1 2021 Commercial Metrics Overview

    Q1 2021 Commercial Metrics Overview May 12, 2021 Exhibit 99.2

  2. Slide 2: Commercial Overview: Q1 Performance Metrics

    ZILRETTA® net sales of $24.6 million in Q1 2021 In Q1 2,044 accounts purchased ZILRETTA Of the 2,044 accounts that purchased in Q1, 90% had purchased in a prior quarter Commercial Overview: Q1 Performance Metrics 2 Flexion primarily sells ZILRETTA to specialty distributors; Flexion recognizes ZILRET

  3. Slide 3: ZILRETTA Net Sales by Quarter

    ZILRETTA Net Sales by Quarter 3 Flexion recognizes ZILRETTA sales upon receipt of product by specialty distributors.

  4. Slide 4: ZILRETTA Demand by Quarter

    ZILRETTA Demand by Quarter 4 Flexion primarily sells ZILRETTA to specialty distributors; Flexion recognizes ZILRETTA sales upon receipt of product by distributors; demand refers to end-user account purchases (physicians, clinics, and certain medical centers or hospitals) who purchase from these spec

  5. Slide 5: In Q1, ~38% of Demand Came from Accounts Purchasing More than 100 Units

    In Q1, ~38% of Demand Came from Accounts Purchasing More than 100 Units 5 Flexion primarily sells ZILRETTA to specialty distributors; Flexion recognizes ZILRETTA sales upon receipt of product by distributors; demand refers to end-user account purchases (physicians, clinics, and certain medical cente

Flexion Therapeutics — Q1 2021 Earnings Presentation on 6ix